Cargando…
Rediscovering Psilocybin as an Antidepressive Treatment Strategy
There has recently been a renewal of interest in psychedelic research on the use of psilocybin in psychiatric treatment and, in particular, for the treatment of major depressive disorder (MDD). Several state-of-the-art studies have provided new insight into the mechanisms of action of psilocybin and...
Autores principales: | Zeiss, Rene, Gahr, Maximilian, Graf, Heiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538432/ https://www.ncbi.nlm.nih.gov/pubmed/34681209 http://dx.doi.org/10.3390/ph14100985 |
Ejemplares similares
-
Psilocybin as an antidepressant strategy - a review of safety aspects
por: Zeiss, R.
Publicado: (2023) -
Impact of serotonin transporter (SERT) binding affinity on the risk of libido disorders related to antidepressants
por: Zeiss, R., et al.
Publicado: (2022) -
Depressive Disorder With Panic Attacks After Replacement of an Intrauterine Device Containing Levonorgestrel: A Case Report
por: Zeiss, René, et al.
Publicado: (2020) -
Risk of Bleeding Associated With Antidepressants: Impact of Causality Assessment and Competition Bias on Signal Detection
por: Zeiss, René, et al.
Publicado: (2021) -
Corrigendum: Risk of Bleeding Associated With Antidepressants: Impact of Causality Assessment and Competition Bias on Signal Detection
por: Zeiss, René, et al.
Publicado: (2021)